Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001035270 | SCV001198593 | uncertain significance | Immunodeficiency, common variable, 2 | 2022-02-05 | criteria provided, single submitter | clinical testing | This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 140 of the TNFRSF13B protein (p.Glu140Lys). This variant is present in population databases (rs199578237, gnomAD 0.01%). This missense change has been observed in individual(s) with clinical features of TNFRSF13B-related conditions (PMID: 19779048, 22884984, 32185379). ClinVar contains an entry for this variant (Variation ID: 834559). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Institute of Human Genetics, |
RCV001035270 | SCV001429112 | uncertain significance | Immunodeficiency, common variable, 2 | 2017-12-13 | criteria provided, single submitter | clinical testing |